ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control

被引:104
作者
Schwartz, Christian [1 ,2 ]
Khan, Adnan R. [1 ,2 ]
Floudas, Achilleas [1 ,2 ]
Saunders, Sean P. [1 ,2 ]
Hams, Emily [1 ,2 ]
Rodewald, Hans-Reimer [3 ]
McKenzie, Andrew N. J. [4 ]
Fallon, Padraic G. [1 ,2 ,5 ]
机构
[1] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Med, Dublin, Ireland
[2] Trinity Coll Dublin, Trinity Translat Med Inst, Dublin, Ireland
[3] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany
[4] MRC, Lab Mol Biol, Cambridge, England
[5] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland
基金
英国惠康基金; 爱尔兰科学基金会;
关键词
INNATE LYMPHOID-CELLS; T-CELLS; TYPE-2; IMMUNITY; MICE REVEAL; B7; FAMILY; RESPONSES; IL-4; PROTECTION; RECEPTOR; PROMOTES;
D O I
10.1084/jem.20170051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Group 2 innate lymphoid cells (ILC2s) are important effector cells driving the initiation of type 2 immune responses leading to adaptive T helper 2 (Th2) immunity. Here we show that ILC2s dynamically express the checkpoint inhibitor molecule PD-L1 during type 2 pulmonary responses. Surprisingly, PD-L1 : PD-1 interaction between ILC2s and CD4(+) T cells did not inhibit the T cell response, but PD-L1-expressing ILC2s stimulated increased expression of GATA3 and production of IL-13 by Th2 cells both in vitro and in vivo. Conditional deletion of PD-L1 on ILC2s impaired early Th2 polarization and cytokine production, leading to delayed worm expulsion during infection with the gastrointestinal helminth Nippostrongylus brasiliensis. Our results identify a novel PD-L1-controlled mechanism for type 2 polarization, with ILC2s mediating an innate checkpoint to control adaptive T helper responses, which has important implications for the treatment of type 2 inflammation.
引用
收藏
页码:2507 / 2521
页数:15
相关论文
共 50 条
  • [31] USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1
    Kuang, Zean
    Liu, Xiaojia
    Zhang, Na
    Dong, Jingwen
    Sun, Cuicui
    Yin, Mingxiao
    Wang, Yuting
    Liu, Lu
    Xiao, Dian
    Zhou, Xinbo
    Feng, Yanchun
    Song, Danqing
    Deng, Hongbin
    CELL DEATH AND DIFFERENTIATION, 2023, 30 (10) : 2249 - 2264
  • [32] Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status
    Shin, Su-Jin
    Jeon, Yoon Kyung
    Kim, Pil-Jong
    Cho, Yong Mee
    Koh, Jaemoon
    Chung, Doo Hyun
    Go, Heounjeong
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (02) : 694 - 702
  • [33] A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma
    Steuer, Conor E.
    Griffith, Christopher C.
    Nannapaneni, Sreenivas
    Patel, Mihir R.
    Liu, Yuan
    Magliocca, Kelly R.
    El-Deiry, Mark W.
    Cohen, Cynthia
    Owonikoko, Taofeek K.
    Shin, Dong M.
    Chen, Zhuo G.
    Saba, Nabil F.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (03) : 710 - 716
  • [34] Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8+ T cells
    Leng, Changsen
    Li, Yin
    Qin, Jianjun
    Ma, Jun
    Liu, Xianben
    Cui, Yingying
    Sun, Haibo
    Wang, Zongfei
    Huai, Xionghuai
    Yui, Yongkui
    Li, Haomiao
    Zhang, Jun
    Zheng, Yan
    Wang, Wei
    Zhui, Jijnwei
    Wang, Qiuming
    ONCOLOGY REPORTS, 2016, 35 (02) : 699 - 708
  • [35] IL-1B enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4+IL-10+ T cell balance and regulates its adhesion, proliferation and migration via PD-L1
    Zhang, Aiping
    Xiong, Yanlian
    Xu, Fenghuang
    Wang, Zhuoya
    Ma, Junjie
    Zhao, Nannan
    Hu, Tao
    Yi, Junzhu
    Zhou, Yuming
    Luan, Xiying
    CELLULAR IMMUNOLOGY, 2020, 352
  • [36] Langerhans cell-like dendritic cells treated with ginsenoside Rh2 regulate the differentiation of Th1 and Th2 cells in vivo
    Liu, Ying
    Wu, Qian
    Li, Peng
    Liu, Weijie
    Jin, Yongri
    Li, Xuwen
    Shi, Xiaolei
    OPEN CHEMISTRY, 2019, 17 (01): : 142 - 150
  • [37] PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease
    Srinivasan, Priya
    Wu, Xiaofang
    Basu, Mousumi
    Rossi, Christopher
    Sandler, Anthony D.
    PLOS MEDICINE, 2018, 15 (01):
  • [38] EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells
    Zhao, Yuetao
    Wang, Xin-Xin
    Wu, Wei
    Long, Haixia
    Huang, Jiani
    Wang, Zhongyu
    Li, Tao
    Tang, Shu
    Zhu, Bo
    Chen, Degao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 517 (02) : 201 - 209
  • [39] BLOC1S1 Control of Vacuolar Organelle Fidelity Modulates Murine TH2 Cell Immunity and Allergy Susceptibility
    Sharma, Rahul
    Wu, Kaiyuan
    Han, Kim
    Russo, Anna Chiara
    Dagur, Pradeep K.
    Combs, Christian A.
    Yao, Xianglan
    Levine, Stewart J.
    Sack, Michael N.
    ALLERGY, 2024,
  • [40] PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions
    Akbari, O.
    Stock, P.
    Singh, A. K.
    Lombardi, V.
    Lee, W-L
    Freeman, G. J.
    Sharpe, A. H.
    Umetsu, D. T.
    DeKruyff, R. H.
    MUCOSAL IMMUNOLOGY, 2010, 3 (01) : 81 - 91